The $75.34m venture financing of Diabeloop was the Medical devices industry’s top venture financing deal as total deals worth $1.1bn were announced globally in May 2022, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 33.5% over the previous month of $1.7bn and a drop of 55% when compared with the last 12-month average, which stood at $2.51bn.
Comparing venture financing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $534.86m. At the country level, the US topped the list in terms of deal value at $534.86m.
In terms of volumes, North America emerged as the top region for Medical devices industry venture financing deals globally, followed by Asia-Pacific and then Europe.
The top country in terms of venture financing deals activity in May 2022 was the US with 51 deals, followed by the China with 22 and Israel with five.
In 2022, as of May, Medical devices venture financing deals worth $9.84bn were announced globally, marking an increase of 10.2% year on year.
Medical devices industry venture financing deals in May 2022: Top deals
The top five Medical devices industry venture financing deals accounted for 29.3% of the overall value during May 2022.
The combined value of the top five Medical devices venture financing deals stood at $331.54m, against the overall value of $1.1bn recorded for the month.
The top five Medical devices industry venture financing deals of May 2022 tracked by GlobalData were:
2) The $70m venture financing of Hello Heart by BlueRun Ventures,Institutional Venture Partners,Maven Ventures,Resolute Ventures and Stripes Group
3) ConvaTec Group $64m venture financing deal with BlueWind Medical
4) The $61.2m venture financing of Shanghai Yuanneng Biological Cryogenic Equipment by Deluxe Family,Employee Stock Ownership Platform,Kaineng Health Technology Group and Shanghai Gaosen Asset Management
5) Alkemi Venture Partners,Chiratae Ventures,HealthQuad,LC Nueva AIF,LeapFrog Investments,Schroders and Spark Growth Ventures $61m venture financing deal with Redcliffe Lifetech
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.